Mitochondrial disease is an umbrella terms for a range of conditions. Some of IMP’s members have information about the diseases on their websites, please follow the links to find out more.
Bezoek de website van VKS voor informatie in het Nederlands.
Visite el sitio web de AEPMI para obtener información en español.
Informationen in deutscher Sprache finden Sie auf der Website der DGM.
Visita il sito web Mitocon per informazioni in italiano.
Conditions associated with mitochondrial disease:
Austosomal dominant optic atrophy (ADOA) Mito Action UMDF
Alpers disease Mito Action MitoCanada The Lily Foundation UMDF
Barth syndrome Mito Action UMDF
Beta-oxidation defects UMDF
Carnitine-acyl-carnitine deficiency UMDF
Carnitine deficiency Mito Action UMDF
Chronic progressive external ophthalmoplegia (CPEO) Mito Action MitoCanada UMDF
Co-enzyme Q10 deficiency Mito Action UMDF
Complex I deficiency UMDF
Complex II deficiency UMDF
Complex III deficiency UMDF
Complex IV deficiency UMDF
Complex V deficiency UMDF
Cytochrome C oxidase deficiency (COX Deficiency)
Carnitine palmitoyltransferase (CPT) I Deficiency UMDF
Carnitine palmitoyltransferase (CPT) II Deficiency UMDF
Creatine deficiency syndromes Mito Action UMDF
DNA Polymerase Gamma, Catalytic Subunit (POLG Mutations) UMDF
Fatty acid oxidation disorders Mito Action
Friedreich’s ataxia Mito Action MitoCanada
Glutaric aciduria type II
Kearns sayre syndrome (KSS) Mito Action Mito Foundation The Lily Foundation UMDF
Lactic acidosis The Lily Foundation MitoCanada UMDF
Leukodystrohpy (LBSL) UMDF
Long chain acyl coA dehydrogenase deficiency (LCAD) MitoCanada UMDF
Long chain L-3 hydroxyacyl-coA dehydrogenase deficiency (LCHAD) UMDF
LHAD
Leber hereditary optic neuropathy (LHON) Mito Action MitoCanada Mito Foundation The Lily Foundation UMDF
Leigh disease or syndrome Mito Action MitoCanada Mito Foundation The Lily Foundation UMDF
Lethal infantile cardiomyopathy (LIC)
Luft disease MitoCanada UMDF
Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) Mito Action MitoCanada Mito Foundation The Lily Foundation UMDF
Medium chain acyl-CoA dehydrogenase (MCAD) MitoCanada UMDF
Mitochondrial carrier related diseases
Mitochondrial cytopathy UMDF
Mitochondrial DNA depletion The Lily Foundation UMDF
Mitochondrial encephalopathy UMDF
Mitochondrial enoyl CoA reductase protein-associated neurodegeneration (MEPAN)
Mitochondrial myopathy Mito Action
Mitochondrial recessive ataxia syndrome (MIRAS) UMDF
Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE) Mito Action MitoCanada Mito Foundation UMDF
Multiple acyl-CoA dehydrogenase deficiency (MAD) / Glutaric aciduria type II UMDF
Multiple mitochondrial DNA deletions The Lily Foundation
Multiple Mitochondrial Dysfunction Syndrome Mito Action
Myoclonic epilepsy with ragged red fibres (MERRF) MitoCanada Mito Foundation The Lily Foundation UMDF
Neuropathy, ataxia, and retinitis pigmentosa (NARP) MitoCanada Mito Foundation The Lily Foundation UMDF
Pearson syndrome MitoCanada The Lily Foundation UMDF
Primary mitochondrial myopathy Mito Action
Progressive External Ophthalmoplegia Mito Foundation
Pyruvate carboxylase deficiency UMDF
Pyruvate dehydrogenase deficiency UMDF
Respiratory chain
Short chain acyl-CoA dehydrogenase (SCAD) MitoCanada UMDF
Short chain 3 hydroxylacyl-CoA dehydrogenase (SCHAD) UMDF
Thymidine Kinase 2 (TKS) Deficiency
Very long chain acyl-CoA dehydrogenase deficiency (VLCAD) UMDF
The information on the IMP website is for general use only. Please speak with your doctor about your personal situation.
IMP is not responsible for content on any websites linked to from this site - the inclusion of any such links does not necessarily imply a recommendation or endorse the views expressed within them.
